ATRA - Atara Biotherapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

37.44M

Cash

153.6M

Avg Qtr Burn

-53.29M

Short % of Float

15.75%

Insider Ownership

2.58%

Institutional Own.

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tab-cel (tabelecleucel) Details Viral infection, Epstein-Barr virus, Nasopharyngeal carcinoma, Solid organ transplant, Hematopoietic cell transplantation	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ATA188 Details Multiple sclerosis, Epstein-Barr virus	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ATA3219 Details Non-Hodgkin lymphoma, Blood cancer, Cancer	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.